This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dsm IP Assets B.v.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Rob Markus: Innovator in Peptide Research
Introduction
Rob Markus is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of peptide research, particularly in the area of appetite regulation during stress. His innovative work has the potential to impact health and wellness significantly.
Latest Patents
Rob Markus holds a patent for a composition comprising a tryptophan-containing peptide. This invention features a Trp/LNAA ratio of more than 0.1, which is designed to decrease eating or appetite during or after stress. This patent highlights his commitment to advancing scientific knowledge and practical applications in nutrition.
Career Highlights
Rob is associated with Dsm IP Assets B.V., where he continues to explore the potential of peptides in various applications. His work is characterized by a focus on the biochemical mechanisms that influence appetite and stress responses.
Collaborations
Rob has collaborated with talented individuals such as Cindy Gerhardt and Joris Kloek. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Rob Markus is a dedicated inventor whose work in peptide research is paving the way for new approaches to appetite management. His contributions are valuable to both the scientific community and the broader public.